Molecular characterization of a Trichinella spiralis aspartic protease and its facilitation role in larval invasion of host intestinal epithelial cells

Jia Xu,Ruo Dan Liu,Sheng Jie Bai,Hui Nan Hao,Wen Wen Yue,Yang Xiu Yue Xu,Shao Rong Long,Jing Cui,Zhong Quan Wang
DOI: https://doi.org/10.1371/journal.pntd.0008269
2020-04-27
PLoS Neglected Tropical Diseases
Abstract:<span><em>T</em>. <em>spiralis</em> aspartic protease has been identified in excretion/secretion (ES) proteins, but its roles in larval invasion are unclear. The aim of this study was to characterize <em>T</em>. <em>spiralis</em> aspartic protease-2 (TsASP2) and assess its roles in <em>T</em>. <em>spiralis</em> invasion into intestinal epithelial cells (IECs) using RNAi.Recombinant TsASP2 (rTsASP2) was expressed and purified. The native TsASP2 of 43 kDa was recognized by anti-rTsASP2 serum in all worm stages except newborn larvae (NBL), and qPCR indicated that TsASP2 transcription was highest at the stage of intestinal infective larvae (IIL). IFA results confirmed that TsASP2 was located in the hindgut, midgut and muscle cells of muscle larvae (ML) and IIL and intrauterine embryos of the female adult worm (AW), but not in NBL. rTsASP2 cleaved several host proteins (human hemoglobin (Hb), mouse Hb, collagen and IgM). The proteolytic activity of rTsASP2 was host-specific, as it hydrolyzed mouse Hb more efficiently than human Hb. The enzymatic activity of rTsASP2 was significantly inhibited by pepstatin A. The expression levels of TsASP2 mRNA and protein were significantly suppressed by RNAi with 5 μM TsASP2-specific siRNA. Native aspartic protease activity in ML crude proteins was reduced to 54.82% after transfection with siRNA. Larval invasion of IECs was promoted by rTsASP2 and inhibited by anti-rTsASP2 serum and siRNA. Furthermore, cell monolayer damage due to larval invasion was obviously alleviated when siRNA-treated larvae were used. The adult worm burden, length of adult worms and female fecundity were clearly reduced in mice challenged using siRNA-treated ML relative to the PBS group,rTsASP2 possesses the enzymatic activity of native aspartic protease and facilitates <em>T</em>. <em>spiralis</em> invasion of host IECs.Trichinellosis has been regarded as a re-emerging or emerging disease, and it is distributed worldwide. Studies investigating <em>T</em>. <em>spiralis</em> ES protein are beneficial to explore potential molecular targets for anti-<em>T</em>. <em>spiralis</em> vaccines. The functions of aspartic protease have been studied in other parasites and demonstrated to be crucial for their parasitism in the host. However, the functions of <em>T</em>. <em>spiralis</em> aspartic protease have not been reported. Here, we expressed and purified a <em>T</em>. <em>spiralis</em> aspartic protease-2 (TsASP2). Our results showed that TsASP2 was expressed in all <em>T</em>. <em>spiralis</em> developmental stages more than NBL and located in the hindgut, midgut and muscle cells of ML and IIL, as well as in areas surrounding embryos within the female uterus. The rTsASP2 possessed aspartic protease activity and functioned to cleave hemoglobin, collagen and IgM. Silencing of the <em>TsASP2</em> gene could significantly decrease the aspartic protease activity in muscle larva crude proteins, larval invasion of IECs and worm development in the host. We conclude that TsASP2 plays an important role in <em>T</em>. <em>spiralis</em> penetration into host intestinal epithelial cells and could be a candidate vaccine target molecule against <em>T</em>. <em>spiralis</em> infection.</span>
tropical medicine,parasitology
What problem does this paper attempt to address?